Medicalgorithmics is entering a business talks with a global MedTech company listed on the NYSE with a multi-billion-dollar business
Medicalgorithmics, a Warsaw Stock Exchange-listed developer of innovative cardiology technologies, is entering a talks with a global, multi-billion-dollar MedTech player—
a company operating in the U.S. and international markets and listed on the New York Stock Exchange. The talks focus on potential collaboration between the two entities regarding the aforementioned company’s use of Medicalgorithmics’ proprietary AI-based technologies in the field of ambulatory cardiac diagnostics. The talks were initiated after the parties signed a mutual non-disclosure agreement (NDA).